Thursday, May 28, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result

KNDS Reports €661m Operating Profit and €33bn Backlog as Dual Frankfurt-Paris IPO Nears Final Hurdle

Jackson Burston by Jackson Burston
May 28, 2026
in Uncategorized
0
KNDS Stock
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

The proposed dual listing of KNDS in Frankfurt and Paris now turns on a single document: a signed audit opinion from PwC. Without it, the summer 2026 window for what could be one of Europe’s largest defence IPOs will close. The auditor has yet to certify the 2025 financial statements because of a compliance review into a €1.89bn Qatar contract from 2013, though that inquiry has cleared current and former employees of any wrongdoing.

The German-French armour group behind the Leopard 2 tank and Caesar howitzer published its full-year numbers on schedule, posting a 15.9% revenue advance to €4.4bn. Operating profit jumped to €661m from €500m a year earlier, lifting the EBIT margin to 15.0% from 13.2%. The munitions segment was the standout performer, with sales climbing 24.7% to €612m. Land Systems Germany contributed €2.5bn and Land Systems France €1.3bn. Headcount rose 7.3% to around 11,000.

Even more striking is the order book. It swelled from €23.5bn to €33.1bn, nearly doubling in two years as NATO allies accelerate rearmament programmes. That pipeline underpins a pre-IPO valuation that analysts put somewhere between €15bn and €20bn.

Yet the free-float structure will be unusually tight. The German government, via KfW, plans to acquire a 40% stake, matching the French state’s existing holding. That leaves just 20% of shares for public trading at listing. Both governments intend to trim their positions to 30% each over the next two to three years, which would expand the free float to about 40% – a level more palatable for index inclusion and institutional investors. For now, liquidity concerns may weigh on the stock’s appeal.

Should investors sell immediately? Or is it worth buying KNDS?

In a final pre-IPO balance-sheet tidying move, KNDS sold 5.8 million shares in gearbox specialist Renk on May 19 via an accelerated bookbuild at €44.95 apiece, netting €269m. The disposal cut its stake in Renk to roughly 10%. A special dividend of up to €2bn for existing shareholders is also under discussion.

Management has locked in governance ahead of the listing. Christian Schulz, formerly CFO of Renk Group, joined the board to chair the audit committee, bringing IPO and defence-sector expertise. The external probe into the Qatar contract, conducted by law firm Freshfields, found no evidence of criminal misconduct, removing what was seen as a key compliance risk. Lazard Inc. has been appointed as financial adviser.

The board is targeting a launch in June or July 2026, subject to market conditions. PwC must deliver its sign-off by the end of May to keep that timetable on track; if it slips, September becomes the fallback. KNDS insists preparations remain “fully in line with the original schedule,” but the waiting game is on.

Ad

KNDS Stock: Buy or Sell?! New KNDS Analysis from May 28 delivers the answer:

The latest KNDS figures speak for themselves: Urgent action needed for KNDS investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from May 28.

KNDS: Buy or sell? Read more here...

Tags: KNDS
Jackson Burston

Jackson Burston

Related Posts

Assembly Biosciences Stock
Analysis

Assembly Biosciences Strengthens Pipeline and Balance Sheet After $115M Upsized Raise

May 28, 2026
The Platform Group Stock
E-Commerce

The Platform Group’s EBITDA Surges 37%, but a Perfect Storm of Headwinds Keeps the Stock in the Doldrums

May 28, 2026
Adidas Stock
Consumer & Luxury

Adidas Transforms into a Data Powerhouse as World Cup Orders Pour In

May 28, 2026
Next Post
DroneShield Stock

DroneShield Heads Into AGM with Record Backlog and a Proxy Adviser’s Rebuke

Palantir Stock

Palantir's Developer Console Upgrade Arrives as Rivals Copy Its Playbook and CEO Sells $54M in Stock

Micron Stock

Micron’s Earnings Test: Can the Memory Chip Giant Live Up to Its Own Lofty Forecast?

Recommended

Broker business

Unveiling the Future of Economic Freedom: Trends in Parallel Economy Conventions

2 years ago
Neutra Stock

Shifting Focus: How Neutra is Pivoting to Clinical Trial Management

2 months ago
TSMC Stock

TSMC Stock Surges on Dual Catalysts: Export License and Next-Gen Chip Progress

5 months ago
Lockheed Stock

Lockheed Martin Navigates Expansion and Legal Challenges

9 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Ubtech Robotics Bolsters Korean Alliance and Boardroom Grip Amid Humanoid Revenue Surge

Ferrexpo’s Double Squeeze: A Kyiv Court Battle and a $100 Million Funding Logjam Keep Shares Frozen

Refined Energy’s Uranium Push Gains Urgency as Board Shuffles and Drilling Progresses

AMD’s Trillion-Dollar Ambition Meets the $500 Ceiling: Strong Earnings Can’t Silence Profit-Takers

Navitas Semiconductor: A $6.7 Billion Bet on AI Data Centers With Only $8.6 Million in Quarterly Sales

Eli Lilly’s Two-Front Victory: A Trillion-Dollar Valuation and a Pharmacy Benefit Win Reshape the Obesity Landscape

Trending

Assembly Biosciences Stock
Analysis

Assembly Biosciences Strengthens Pipeline and Balance Sheet After $115M Upsized Raise

by SiterGedge
May 28, 2026
0

Assembly Biosciences has emerged from the EASL Congress in Barcelona with more than just data. The biotech...

The Platform Group Stock

The Platform Group’s EBITDA Surges 37%, but a Perfect Storm of Headwinds Keeps the Stock in the Doldrums

May 28, 2026
Adidas Stock

Adidas Transforms into a Data Powerhouse as World Cup Orders Pour In

May 28, 2026
Ubtech Robotics Stock

Ubtech Robotics Bolsters Korean Alliance and Boardroom Grip Amid Humanoid Revenue Surge

May 28, 2026
Ferrexpo Stock

Ferrexpo’s Double Squeeze: A Kyiv Court Battle and a $100 Million Funding Logjam Keep Shares Frozen

May 28, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Assembly Biosciences Strengthens Pipeline and Balance Sheet After $115M Upsized Raise
  • The Platform Group’s EBITDA Surges 37%, but a Perfect Storm of Headwinds Keeps the Stock in the Doldrums
  • Adidas Transforms into a Data Powerhouse as World Cup Orders Pour In

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com